Envision Summit 2025: Incorporating EVO ICL into your practice
February 16th 2025At the Envision Summit 2025 in San Juan, Puerto Rico, Arjan Hura, MD, talked about EVO ICL surgery, its benefits, and how every ophthalmologist has the ability and training to conduct the surgery even if they aren't aware.
Envision Summit 2025: Surgical challenges of a pediatric retinal detachment secondary to trauma
February 16th 2025At the Envision Summit 2025 in San Juan, Puerto Rico, Nita Valikodath, MD, MS, gave insight into a challenging case of a 14-year-old boy who had trauma-related retinal detachment in his right eye, where a further macula-on retinal detachment with retinal dialysis was found in the left.
Envision Summit 2025: AI in the diagnosis of ocular tumors
February 15th 2025At the Envision Summit 2025 in San Juan, Puerto Rico, Carol Karp, MD, discussed new research presented by her fellows at the meeting on AI for the diagnosis of ocular surface tumors as well as a new "tear biopsy" for the detection of cancer.
Envision Summit 2025: Advice on treating periorbital eye injuries
February 15th 2025At the Envision Summit 2025 in San Juan, Puerto Rico, Brittany Simmons, MD, discussed periorbital injuries and how they can affect the soft tissue and bones around the eye and gives insight into how clinicians should best go about treating it.
Age and gender may play a part in patient outcomes following ocular gene therapy
February 15th 2025The University of Bristol research team used animal models to compare patient responses to AAV therapy, studying male and female eye cells across different age groups (young, middle-aged and older patients)
Clearside Biomedical presents new data from CLS-AX ODYSSEY phase 2b trial
February 11th 2025The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib injectable suspension) in participants with neovascular age-related macular degeneration.
Shaffer-Hetherington-Hoskins Lecture at the 2025 Glaucoma 360 meeting
February 10th 2025M. Roy Wilson, presented the Shaffer-Hetherington-Hoskins Lecture at the Glaucoma 360 meeting held in San Francisco, California. This lecture was entitled, "Rethinking Race as a Risk Factor for Glaucoma: What Really Matters?"
DMEI resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
February 10th 2025Ooms' poster at the Association of University Professors of Ophthalmology annual meeting highlighted a study on gray area complications in strabismus surgery, showing that trainees are more likely than attendings to disclose these complications despite having similar baseline anxiety levels. Ooms is a PGY-4 ophthalmology resident at the Dean McGee Eye Institute.